Aspirin/Pravastatin Sodium

阿司匹林/普伐他汀钠

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAspirin/Pravastatin Sodium
Drug Alias Name乙酰水杨酸/普伐他汀钠Pravastatin Sodium and Aspirin阿司匹林普伐他汀钠Pravastatin/AspirinPravastatin Sodium/Aspirin +[10] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsHMG-CoA reductase inhibitors
TargetsHMG-CoA reductaseCyclooxygenases
Therapy Area/IndicationsCoronary Artery Disease
Global Approved IndicationsCoronary Artery Disease
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2003/06/24
Country/TerritoryUnited States
CombinationsYes AspirinPravastatin sodium
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsCoronary Artery Disease

Other Information

ATC CodeC10BX02
Related LinksN/A